Concepedia

Clay L. Efferson

CL

15

Publications

597

Citations

13

H-Index

2002

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Gynecologic Oncology Group

United States Military Academy

Icahn School of Medicine at Mount Sinai

Clay L. Efferson is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, systems biology, and tumor biology.

Top concepts

Publications per year

2002–2012

15

Publications

15

Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model

Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware et al. · Cancer Research · 2010 · 92 citations · Full text

, , +14

Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a <i>Pten</i> -Deficient Mouse Model of Prostate Cancer

Weisheng Zhang, Joe Jiang Zhu, Clay L. Efferson et al. · Cancer Research · 2009 · 76 citations

Down‐regulation of the Notch pathway mediated by a γ‐secretase inhibitor induces anti‐tumour effects in mouse models of T‐cell leukaemia

Jennifer Tammam, C. Ware, Clay L. Efferson et al. · British Journal of Pharmacology · 2009 · 75 citations · Full text

Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model

Ryo Miyahara, S. Banerjee, K. Kawano et al. · Cancer Gene Therapy · 2006 · 54 citations · Full text

, , +14

Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells

Naotake Tsuda, Kouichiro Kawano, Clay L. Efferson et al. · International Journal of Oncology · 2005 · 44 citations

, , +13

Rows per page

1–5 of 15